The Los Angeles Project (LAP), a venture-backed biotech startup that’s been operating quietly for the past year, comes out of stealth today. Its pre-seed round was funded by 1517 and other undisclosed investors. Josie Zayner and Cathy Tie, the company’s co-founders, have been building a high-throughput gene-editing platform and knowledge database focused on the genetic modification of animal embryos. One of the company’s most exciting, and eccentric, objectives? “I want to build a unicorn,” Cathy told me. In Josie’s words, LAP is a “generational company creating a new lineage of biotech” and, hopefully, “a new lineage of life.”
Read Full Article »
